GeneDx Holdings
WGS • NASDAQ
GeneDx Holdings is a medical - healthcare information services company in the healthcare sector trading on NASDAQ, led by CEO Katherine A. Stueland, with a market cap of $2.8B.
CEOKatherine A. Stueland
Market Cap$2.8B
Medical - Healthcare Information Services
Healthcare
Employees1.0K
Websitegenedx.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for GeneDx Holdings
Date
Wednesday, April 29, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.04
Revenue Estimate
$116.3M
Earnings History
Past 12 earnings reports for GeneDx Holdings
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 23, 2026 | Q4 2025 | $0.14Est: $0.12 | +16.7% | $121.0MEst: $119.9M | +0.9% |  10-K |
| Oct 28, 2025 | Q3 2025 | $0.49Est: $0.37 | +32.4% | $116.7MEst: $104.3M | +11.9% | 10-Q |
| Jul 29, 2025 | Q2 2025 | $0.50Est: $0.10 | +400.0% | $102.7MEst: $85.2M | +20.5% | 10-Q |
| Apr 30, 2025 | Q1 2025 | $0.27Est: $0.09 | +200.0% | $87.1MEst: $79.8M | +9.2% | 10-Q |
| Feb 18, 2025 | Q4 2024 | $0.60Est: $0.10 | +500.0% | $95.6MEst: $82.2M | +16.3% | 10-K |
| Oct 29, 2024 | Q3 2024 | $0.04Est: -$0.21 | +119.0% | $76.9MEst: $65.0M | +18.3% | 10-Q |
| Jul 30, 2024 | Q2 2024 | -$0.10Est: -$0.30 | +66.7% | $70.5MEst: $59.2M | +19.0% | 10-Q |
| Apr 29, 2024 | Q1 2024 | -$0.33Est: -$0.67 | +50.7% | $62.4MEst: $49.5M | +26.2% | 10-Q |
| Feb 20, 2024 | Q4 2023 | -$0.69Est: -$0.75 | +8.0% | $57.4MEst: $55.4M | +3.6% | 10-K |
| Oct 30, 2023 | Q3 2023 | -$1.22Est: -$1.31 | +6.9% | $53.3MEst: $52.4M | +1.7% | — |
| Aug 8, 2023 | Q2 2023 | -$1.65Est: -$1.31 | -26.0% | $48.7MEst: $47.6M | +2.3% | 10-Q |
| May 9, 2023 | Q1 2023 | -$2.44Est: -$2.80 | +12.9% | $43.1MEst: $38.0M | +13.5% | — |